These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 11779396

  • 1. Safety, efficacy and effectiveness of cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in adults and children.
    Belshe RB, Gruber WC.
    Philos Trans R Soc Lond B Biol Sci; 2001 Dec 29; 356(1416):1947-51. PubMed ID: 11779396
    [Abstract] [Full Text] [Related]

  • 2. Current status of live attenuated influenza virus vaccine in the US.
    Belshe RB.
    Virus Res; 2004 Jul 29; 103(1-2):177-85. PubMed ID: 15163507
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA, Gaglani MJ, Kozinetz CA, Herschler GB, Fewlass C, Harvey D, Zimmerman N, Glezen WP.
    Pediatrics; 2007 Sep 29; 120(3):e553-64. PubMed ID: 17698577
    [Abstract] [Full Text] [Related]

  • 7. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years.
    Belshe RB, Nichol KL, Black SB, Shinefield H, Cordova J, Walker R, Hessel C, Cho I, Mendelman PM.
    Clin Infect Dis; 2004 Oct 01; 39(7):920-7. PubMed ID: 15472840
    [Abstract] [Full Text] [Related]

  • 8. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.
    Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M.
    N Engl J Med; 1998 May 14; 338(20):1405-12. PubMed ID: 9580647
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
    Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, Treanor J, Zangwill K, Hayden FG, Bernstein DI, Kotloff K, King J, Piedra PA, Block SL, Yan L, Wolff M.
    J Infect Dis; 2000 Mar 14; 181(3):1133-7. PubMed ID: 10720541
    [Abstract] [Full Text] [Related]

  • 12. Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine.
    Belshe R, Lee MS, Walker RE, Stoddard J, Mendelman PM.
    Expert Rev Vaccines; 2004 Dec 14; 3(6):643-54. PubMed ID: 15606348
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cold-adapted, live attenuated influenza vaccine.
    Glezen WP.
    Expert Rev Vaccines; 2004 Apr 14; 3(2):131-9. PubMed ID: 15056039
    [Abstract] [Full Text] [Related]

  • 15. Live attenuated versus inactivated influenza vaccine in infants and young children.
    Belshe RB, Edwards KM, Vesikari T, Black SV, Walker RE, Hultquist M, Kemble G, Connor EM, CAIV-T Comparative Efficacy Study Group.
    N Engl J Med; 2007 Feb 15; 356(7):685-96. PubMed ID: 17301299
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Trivalent intranasal influenza vaccine, live.
    McCarthy MW, Kockler DR.
    Ann Pharmacother; 2004 Dec 15; 38(12):2086-93. PubMed ID: 15494383
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of a single dose of live attenuated influenza vaccine in previously unvaccinated children: a post hoc analysis of three studies of children aged 2 to 6 years.
    Block SL, Toback SL, Yi T, Ambrose CS.
    Clin Ther; 2009 Oct 15; 31(10):2140-7. PubMed ID: 19922885
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004.
    Halloran ME, Piedra PA, Longini IM, Gaglani MJ, Schmotzer B, Fewlass C, Herschler GB, Glezen WP.
    Vaccine; 2007 May 16; 25(20):4038-45. PubMed ID: 17395338
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.